In a 2-year trial, acute pancreatitis was reported in 8 semaglutide-treated patients (0.27 cases per 100 patient-years) and 10 placebo-treated patients (0.33 cases per 100 patient-years), both on a background of standard of care.1 In trials of patients receiving oral semaglutide, pancreatitis was reported as a serious adverse event in 6 patients (0.1 events per 100 patient-years) receiving semaglutide versus 1 in comparator-treated patients (less than 0.1 events per 100 patient-years)
"Obesity is a chronic, progressive condition that will get worse
Clinical studies show that low doses of MT-II administered subcutaneously result in noticeable tanning within days, even without UV exposure
Medication is invoiced after the consultation, not before
The symptoms of pellagra are commonly referred to as the three "Ds": sun-sensitive dermatitis, diarrhea, and dementia
These problems have stimulated the search for alternative pharmacologically favorable cysteine pro-drugs like NAC amide (NACA) or NAC-Methyl esther (NAC-Me)